Denosumab Injection for Osteoporosis from Canada
Prolia-brand denosumab, RANKL inhibitor antibody in 60mg prefilled syringes for retail, preventing bone resorption through immunological modulation. HTS 3002.15.00.91 for antibody-based immunological products in retail measured forms.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Include patient information leaflets to prove retail intent
• Validate against EU/ICH stability guidelines for transborder shipments